stoxline Quote Chart Rank Option Currency Glossary
  
CONMED Corporation (CNMD)
80.08  -0.06 (-0.07%)    03-28 16:00
Open: 80.23
High: 81.22
Volume: 407,825
  
Pre. Close: 80.14
Low: 79.54
Market Cap: 2,465(M)
Technical analysis
2024-03-28 4:50:31 PM
Short term     
Mid term     
Targets 6-month :  96.08 1-year :  101.56
Resists First :  82.26 Second :  86.95
Pivot price 79.37
Supports First :  74.66 Second :  62.12
MAs MA(5) :  77.93 MA(20) :  80.31
MA(100) :  96.42 MA(250) :  107.45
MACD MACD :  -2.2 Signal :  -2.6
%K %D K(14,3) :  36 D(3) :  25.8
RSI RSI(14): 46.8
52-week High :  138.47 Low :  74.66
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CNMD ] has closed below upper band by 45.3%. Bollinger Bands are 10.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 81.28 - 81.7 81.7 - 81.96
Low: 78.56 - 79.1 79.1 - 79.45
Close: 79.3 - 80.12 80.12 - 80.65
Company Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Headline News

Thu, 28 Mar 2024
Is CONMED (NYSE:CNMD) Using Too Much Debt? - Simply Wall St

Thu, 28 Mar 2024
CONMED Co. (NYSE:CNMD) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Thu, 28 Mar 2024
CONMED Co. (NYSE:CNMD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Tue, 26 Mar 2024
3735 Shares in CONMED Co. (NYSE:CNMD) Purchased by Legato Capital Management LLC - Defense World

Tue, 05 Mar 2024
Here's Why You Should Retain CONMED (CNMD) Stock for Now - Nasdaq

Thu, 15 Feb 2024
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26% - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 31 (M)
Shares Float 31 (M)
Held by Insiders 0.5 (%)
Held by Institutions 119.9 (%)
Shares Short 3,960 (K)
Shares Short P.Month 4,800 (K)
Stock Financials
EPS 2.03
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 27.12
Profit Margin 5.1 %
Operating Margin 12.2 %
Return on Assets (ttm) 3.4 %
Return on Equity (ttm) 8.1 %
Qtrly Rev. Growth 30.3 %
Gross Profit (p.s.) 0
Sales Per Share 40.28
EBITDA (p.s.) 6.42
Qtrly Earnings Growth 21.2 %
Operating Cash Flow 125 (M)
Levered Free Cash Flow 182 (M)
Stock Valuations
PE Ratio 39.25
PEG Ratio 0.6
Price to Book value 2.95
Price to Sales 1.98
Price to Cash Flow 19.66
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android